Understanding how a specific protein activates the immune response linked to Alzheimer's and other diseases
Molecular mechanism of NLRP3 inflammasome activation
['FUNDING_R01'] · WAYNE STATE UNIVERSITY · NIH-11077336
This study is looking at how a protein called Nek7 affects a part of the immune system that can cause problems like Alzheimer's when it gets activated the wrong way, and the goal is to find new ways to help treat diseases linked to this process.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WAYNE STATE UNIVERSITY (nih funded) |
| Locations | 1 site (DETROIT, UNITED STATES) |
| Trial ID | NIH-11077336 on ClinicalTrials.gov |
What this research studies
This research investigates the NLRP3 inflammasome, a key component of the immune system that can contribute to diseases like Alzheimer's when activated improperly. The team will explore the role of a protein called Nek7 in this activation process, aiming to uncover the molecular mechanisms involved. By studying how Nek7 interacts with the NLRP3 inflammasome, the researchers hope to identify new therapeutic strategies for treating inflammatory diseases. Patients may benefit from insights that could lead to innovative treatments for conditions associated with NLRP3 activation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related inflammatory conditions.
Not a fit: Patients with non-inflammatory conditions or those not affected by Alzheimer's or related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for Alzheimer's disease and other inflammatory disorders.
How similar studies have performed: Previous research has shown promising results in understanding the NLRP3 inflammasome, but this specific investigation into Nek7 is novel.
Where this research is happening
DETROIT, UNITED STATES
- WAYNE STATE UNIVERSITY — DETROIT, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HE, YUAN — WAYNE STATE UNIVERSITY
- Study coordinator: HE, YUAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Atherosclerotic Cardiovascular Disease, atherosclerotic disease